Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11520 posts found.

Iressa successor enters phase III

July 19, 2005 Research and Development, Sales and Marketing

AstraZeneca's oncology compound ZD6474 has entered phase III trials after positive results in trials in non-small cell lung cancer.The drug, …
News

Arimidex approved for post-surgery cancer prevention

July 13, 2005 Sales and Marketing

News

Getting inside the customer’s head

July 11, 2005 Sales and Marketing

Doctors are a diverse group of people. From GPs to specialists, with the more than 60 areas of medicine that …
Feature

Because they’re worth it?

July 11, 2005 Sales and Marketing

Feature

ABPI sets up links to clinical trials databases

July 7, 2005 Sales and Marketing

Website links to details of more than 4,000 clinical trials have been published by the ABPI, as the global agreement …
News

Pfizer pulls out of Daxas collaboration

July 7, 2005 Sales and Marketing Daxas, Nycomed, Pfizer

Pfizer has pulled out of an agreement with Altana Pharma to develop and market a new treatment for asthma and …
News

One Europe for pharma marketers?

July 6, 2005 Sales and Marketing

Pharma economists will tell you that the world has a market 'top three'. The US is way ahead in the …
Feature

No more Alton Towers? UK pharma downsizes its hospitality

July 6, 2005 Sales and Marketing

UK-based pharmaceutical companies have pre-empted strict new European rules on entertaining healthcare professionals by imposing their own restrictions.The companies are …
News

Lilly buys rights to novel diabetes drug

July 6, 2005 Research and Development, Sales and Marketing

Eli Lilly has signed a licensing agreement with Japanese pharmaceutical company Taisho for TS-021, a novel treatment for type II …
News

Orphans join European pharma family

July 5, 2005 Sales and Marketing

Feature

Antidepressants come under FDA review again

July 4, 2005 Sales and Marketing

The FDA is conducting another review of antidepressants to determine whether the drugs increase the risk of suicidal behaviour in …
News

GSK excited about new vaccines

July 4, 2005 Sales and Marketing

GlaxoSmithKline has updated investors on its vaccine pipeline, with the company expecting to launch five major vaccines within as many …
News

Bright future for new antidepressants

June 30, 2005 Research and Development, Sales and Marketing

News

Humira receives two European recommendations

June 29, 2005 Sales and Marketing

Abbott's Humira has moved closer to European approval as a first-line treatment of moderate to severe early rheumatoid arthritis in …
News

New products key to Schering growth

June 29, 2005 Sales and Marketing

Schering has reiterated its goal of achieving an 18% operating margin in 2006 and is predicting further growth in the …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025